Prolacta Bioscience: Clinical Trials

1 trial sponsored by Prolacta Bioscience, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1
Phase 31Active not recruiting 1

Follow Prolacta Bioscience: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23

Conditions studied

Enterocolitis, Necrotizing (1)  ·  Sepsis (1)

Countries

Sweden (1)

Top investigators

Thomas R Abrahamsson, MD, PhD (1)

Results publications

PMID 34815288, PMID 38545091